Literature DB >> 16614795

A -16C>T substitution in the 5' UTR of the puratrophin-1 gene is prevalent in autosomal dominant cerebellar ataxia in Nagano.

Takako Ohata1,2, Kunihiro Yoshida3,4,5, Haruya Sakai1, Haruka Hamanoue1, Takeshi Mizuguchi1, Yusaku Shimizu6, Tomomi Okano6, Fumio Takada2, Kinya Ishikawa7, Hidehiro Mizusawa7, Ko-Ichiro Yoshiura8, Yoshimitsu Fukushima9, Shu-Ichi Ikeda6, Naomichi Matsumoto1.   

Abstract

The molecular bases of autosomal dominant cerebellar ataxia (ADCA) have been increasingly elucidated, but 17-50% of ADCA families still remain genetically undefined in Japan. In this study we investigated 67 genetically undefined ADCA families from the Nagano prefecture, and found that 63 patients from 51 families possessed the -16C>T change in the puratrophin-1 gene, which was recently found to be pathogenic for 16q22-linked ADCA. Most patients shared a common haplotype around the puratrophin-1 gene. All patients with the -16C>T change had pure cerebellar ataxia with middle-aged or later onset. Only one patient in a large, -16C>T positive family did not have this change, but still shared a narrowed haplotype with, and was clinically indistinguishable from, the other affected family members. In Nagano, 16q22-linked ADCA appears to be much more prevalent than either SCA6 or dentatorubral-pallidoluysian atrophy (DRPLA), and may explain the high frequency of spinocerebellar ataxia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16614795     DOI: 10.1007/s10038-006-0385-6

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  27 in total

1.  SCA17, a novel autosomal dominant cerebellar ataxia caused by an expanded polyglutamine in TATA-binding protein.

Authors:  K Nakamura; S Y Jeong; T Uchihara; M Anno; K Nagashima; T Nagashima; S Ikeda; S Tsuji; I Kanazawa
Journal:  Hum Mol Genet       Date:  2001-07-01       Impact factor: 6.150

2.  An autosomal dominant cerebellar ataxia linked to chromosome 16q22.1 is associated with a single-nucleotide substitution in the 5' untranslated region of the gene encoding a protein with spectrin repeat and Rho guanine-nucleotide exchange-factor domains.

Authors:  Kinya Ishikawa; Shuta Toru; Taiji Tsunemi; Mingshun Li; Kazuhiro Kobayashi; Takanori Yokota; Takeshi Amino; Kiyoshi Owada; Hiroto Fujigasaki; Masaki Sakamoto; Hiroyuki Tomimitsu; Minoru Takashima; Jiro Kumagai; Yoshihiro Noguchi; Yoshiyuki Kawashima; Norio Ohkoshi; Gen Ishida; Manabu Gomyoda; Mari Yoshida; Yoshio Hashizume; Yuko Saito; Shigeo Murayama; Hiroshi Yamanouchi; Toshio Mizutani; Ikuko Kondo; Tatsushi Toda; Hidehiro Mizusawa
Journal:  Am J Hum Genet       Date:  2005-07-06       Impact factor: 11.025

3.  Identification of the spinocerebellar ataxia type 2 gene using a direct identification of repeat expansion and cloning technique, DIRECT.

Authors:  K Sanpei; H Takano; S Igarashi; T Sato; M Oyake; H Sasaki; A Wakisaka; K Tashiro; Y Ishida; T Ikeuchi; R Koide; M Saito; A Sato; T Tanaka; S Hanyu; Y Takiyama; M Nishizawa; N Shimizu; Y Nomura; M Segawa; K Iwabuchi; I Eguchi; H Tanaka; H Takahashi; S Tsuji
Journal:  Nat Genet       Date:  1996-11       Impact factor: 38.330

Review 4.  Clinical features and classification of inherited ataxias.

Authors:  A E Harding
Journal:  Adv Neurol       Date:  1993

5.  CAG repeat expansion in the TATA box-binding protein gene causes autosomal dominant cerebellar ataxia.

Authors:  H Fujigasaki; J J Martin; P P De Deyn; A Camuzat; D Deffond; G Stevanin; B Dermaut; C Van Broeckhoven; A Dürr; A Brice
Journal:  Brain       Date:  2001-10       Impact factor: 13.501

6.  A neurological disease caused by an expanded CAG trinucleotide repeat in the TATA-binding protein gene: a new polyglutamine disease?

Authors:  R Koide; S Kobayashi; T Shimohata; T Ikeuchi; M Maruyama; M Saito; M Yamada; H Takahashi; S Tsuji
Journal:  Hum Mol Genet       Date:  1999-10       Impact factor: 6.150

7.  Missense mutations in the regulatory domain of PKC gamma: a new mechanism for dominant nonepisodic cerebellar ataxia.

Authors:  Dong-Hui Chen; Zoran Brkanac; Christophe L M J Verlinde; Xiao-Jian Tan; Laura Bylenok; David Nochlin; Mark Matsushita; Hillary Lipe; John Wolff; Magali Fernandez; P J Cimino; Thomas D Bird; Wendy H Raskind
Journal:  Am J Hum Genet       Date:  2003-03-17       Impact factor: 11.025

8.  Regional features of autosomal-dominant cerebellar ataxia in Nagano: clinical and molecular genetic analysis of 86 families.

Authors:  Yusaku Shimizu; Kunihiro Yoshida; Tomomi Okano; Shinji Ohara; Takao Hashimoto; Yoshimitsu Fukushima; Shu-Ichi Ikeda
Journal:  J Hum Genet       Date:  2004-10-08       Impact factor: 3.172

9.  Difference in disease-free survival curve and regional distribution according to subtype of spinocerebellar ataxia: a study of 1,286 Japanese patients.

Authors:  Hirofumi Maruyama; Yuishin Izumi; Hiroyuki Morino; Masaya Oda; Hiromasa Toji; Shigenobu Nakamura; Hideshi Kawakami
Journal:  Am J Med Genet       Date:  2002-07-08

Review 10.  The hereditary spinocerebellar ataxias in Japan.

Authors:  H Sasaki; I Yabe; K Tashiro
Journal:  Cytogenet Genome Res       Date:  2003       Impact factor: 1.636

View more
  14 in total

1.  Spinocerebellar ataxia type 4 and 16q22.1-linked Japanese ataxia are not allelic.

Authors:  Yorck Hellenbroich; Veronica Bernard; Christine Zühlke
Journal:  J Neurol       Date:  2008-02-25       Impact factor: 4.849

2.  A Japanese case of SCA14 with the Gly128Asp mutation.

Authors:  Hiroshi Morita; Kunihiro Yoshida; Kayo Suzuki; Shu-Ichi Ikeda
Journal:  J Hum Genet       Date:  2006-09-22       Impact factor: 3.172

3.  Severity and progression rate of cerebellar ataxia in 16q-linked autosomal dominant cerebellar ataxia (16q-ADCA) in the endemic Nagano Area of Japan.

Authors:  Kunihiro Yoshida; Yusaku Shimizu; Hiroshi Morita; Tomomi Okano; Haruya Sakai; Takako Ohata; Naomichi Matsumoto; Katsuya Nakamura; Ko-ichi Tazawa; Shinji Ohara; Kenichi Tabata; Atsushi Inoue; Shunichi Sato; Yasuhiro Shimojima; Takeshi Hattori; Masao Ushiyama; Shu-ichi Ikeda
Journal:  Cerebellum       Date:  2009-03       Impact factor: 3.847

4.  Past, present and future therapeutics for cerebellar ataxias.

Authors:  D Marmolino; M Manto
Journal:  Curr Neuropharmacol       Date:  2010-03       Impact factor: 7.363

5.  Analysis of an insertion mutation in a cohort of 94 patients with spinocerebellar ataxia type 31 from Nagano, Japan.

Authors:  Haruya Sakai; Kunihiro Yoshida; Yusaku Shimizu; Hiroshi Morita; Shu-ichi Ikeda; Naomichi Matsumoto
Journal:  Neurogenetics       Date:  2010-04-28       Impact factor: 2.660

6.  Spectrum and prevalence of autosomal dominant spinocerebellar ataxia in Hokkaido, the northern island of Japan: a study of 113 Japanese families.

Authors:  Rehana Basri; Ichiro Yabe; Hiroyuki Soma; Hidenao Sasaki
Journal:  J Hum Genet       Date:  2007-09-05       Impact factor: 3.172

7.  Spinocerebellar ataxia type 31 is associated with "inserted" penta-nucleotide repeats containing (TGGAA)n.

Authors:  Nozomu Sato; Takeshi Amino; Kazuhiro Kobayashi; Shuichi Asakawa; Taro Ishiguro; Taiji Tsunemi; Makoto Takahashi; Tohru Matsuura; Kevin M Flanigan; Sawa Iwasaki; Fumitoshi Ishino; Yuko Saito; Shigeo Murayama; Mari Yoshida; Yoshio Hashizume; Yuji Takahashi; Shoji Tsuji; Nobuyoshi Shimizu; Tatsushi Toda; Kinya Ishikawa; Hidehiro Mizusawa
Journal:  Am J Hum Genet       Date:  2009-10-29       Impact factor: 11.025

8.  Molecular genetics of human myopia: an update.

Authors:  Terri L Young
Journal:  Optom Vis Sci       Date:  2009-01       Impact factor: 1.973

9.  Redefining the disease locus of 16q22.1-linked autosomal dominant cerebellar ataxia.

Authors:  Takeshi Amino; Kinya Ishikawa; Shuta Toru; Taro Ishiguro; Nozomu Sato; Taiji Tsunemi; Miho Murata; Kazuhiro Kobayashi; Johji Inazawa; Tatsushi Toda; Hidehiro Mizusawa
Journal:  J Hum Genet       Date:  2007-07-05       Impact factor: 3.172

10.  Plekhg4 is a novel Dbl family guanine nucleotide exchange factor protein for rho family GTPases.

Authors:  Meghana Gupta; Elena Kamynina; Samantha Morley; Stacey Chung; Nora Muakkassa; Hong Wang; Shayna Brathwaite; Gaurav Sharma; Danny Manor
Journal:  J Biol Chem       Date:  2013-04-09       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.